المؤلفون: М. В. Кручинина, М. И. Воевода, С. А. Курилович, А. А. Громов, В. А. Баум, Е. Г. Немцова, Е. В. Логвиненко, Н. А. Ковалькова, В. М. Генералов, Б. Н. Зайцев, В. Н. Кручинин, С. В. Рыхлицкий, Б. А. Князев, В. В. Герасимов, А. Г. Покровский, В. О. Пустыльняк, С. В. Чересиз, Г. Р. Сакаева, А. И. Корбут, В. Д. Анцыгин

المصدر: Архивъ внутренней медицины, Vol 0, Iss 2, Pp 12-17 (2014)

مصطلحات موضوعية: liver cirrhosis, class child–pugh, the optical parameters, erythrocytes, serum, Internal medicine, RC31-1245

وصف الملف: electronic resource

Relation: https://www.medarhive.ru/jour/article/view/276; https://doaj.org/toc/2226-6704; https://doaj.org/toc/2411-6564

URL الوصول: https://doaj.org/article/a596e2bf3f5d481fb042e892bf34aa0c

المؤلفون: М. И. Воевода, М. В. Кручинина, С. Е. Пельтек, С. А. Курилович, В. Н. Кручинин, Е. В. Спесивцев, С. В. Рыхлицкий, В. А. Володин, В. М. Генералов, В. В. Герасимов, Б. А. Князев

المصدر: Архивъ внутренней медицины, Vol 0, Iss 4, Pp 46-54 (2012)

مصطلحات موضوعية: diffuse liver diseases, fibrosis, diagnostics, optical methods for studying blood, screening, Internal medicine, RC31-1245

وصف الملف: electronic resource

Relation: https://www.medarhive.ru/jour/article/view/117; https://doaj.org/toc/2226-6704; https://doaj.org/toc/2411-6564

URL الوصول: https://doaj.org/article/80212873421f427b8d8dcb16f7d487d2

المؤلفون: M. V. Kruchinina, V. N. Kruchinin, A. A. Gromov, M. V. Shashkov, A. S. Sokolova, I. N. Yakovina, A. A. Shestov, М. В. Кручинина, В. Н. Кручинин, А. А. Громов, М. В. Шашков, А. С. Соколова, И. Н. Яковина, А. А. Шестов

المساهمون: The study was carried out within the framework of the project “Epidemiological monitoring of the state of public health and the study of molecular genetic and molecular biological mechanisms for the development of common diseases in Siberia to improve approaches to their diagnosis, prevention and treatment”, No. 122031700094-5., Работа выполнена в рамках темы государственного задания «Эпидемиологический мониторинг состояния здоровья населения и изучение молекулярно-генетических и молекулярно-биологических механизмов развития распространенных терапевтических заболеваний в Сибири для совершенствования подходов к их диагностике, профилактике и лечению», Рег. № 122031700094-5.

المصدر: Siberian journal of oncology; Том 21, № 2 (2022); 65-80 ; Сибирский онкологический журнал; Том 21, № 2 (2022); 65-80 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2022-21-2

مصطلحات موضوعية: сыворотка крови, colorectal cancer, fatty acids, lipidomics, erythrocytes, blood serum, колоректальный рак, жирные кислоты, липидомика, эритроциты

وصف الملف: application/pdf

Relation: https://www.siboncoj.ru/jour/article/view/2091/971; Ferlay J., Soerjomataram I., Dikshit R., Eser S., Mathers C., Rebelo M., Parkin D.M., Forman D., Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5): 359–86. doi:10.1002/ijc.29210.; Garborg K., Holme O., Løberg M., Kalager M., Adami H.O., Bretthauer M. Current status of screening for colorectal cancer. Ann Oncol. 2013; 24(8): 1963–72. doi:10.1093/annonc/mdt157.; Brenner H., Arndt V., Stürmer T. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Arch Intern Med. 2002; 162(19): 2249. doi:10.1001/archinte.162.19.2249.; Pignone M., Rich M., Teutsch S.M., Berg A.O., Lohr A.N. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002; 137(2): 132–41. doi:10.7326/0003-4819-137-2-200207160-00015.; Bian X., Qian Y., Tan B., Li K., Hong X., Wong C.C., Fu L., Zhang D., Li D., Wu J.-L. In-depth mapping carboxylic acid metabolome reveals the potential biomarkers in colorectal cancer through characteristic fragment ions and metabolic flux. Anal Chim Acta. 2020; 1128: 62–71. doi:10.1016/j.aca.2020.06.064.; Monedeiro F., Monedeiro-Milanowski M., Ligor T., Buszewski B. A Review of GC‐Based Analysis of Non‐Invasive Biomarkers of Colorectal Cancer and Related Pathways. J Clin Med. 2020; 9: 3191–224. doi:10.3390/jcm9103191.; Sun L., Kang Q., Pan Y., Li N., Wang X., He Y., Wang H., Yu D., Xie H., Yang L., Lu Y., Jin P., Sheng J. Serum metabolite profiling of familial adenomatous polyposis using ultra performance liquid chromatography and tandem mass spectrometry. Cancer Biol Ther. 2019; 20(7): 1–12. doi:10.1080/15384047.2019.1595277.; Arab L., Akbar J. Biomarkers and the measurement of fatty acids. Public Health Nutr. 2002; 5: 865–71. doi:10.1079/phn2002391.; Zeleniuch-Jacquotte A., Chajes V., Van Kappel A.L., Riboli E., Toniolo P. Reliability of fatty acid composition in human serum phospholipids. Eur J Clin Nutr. 2000; 54: 367–72. doi:10.1038/sj.ejcn.1600964.; Katan M.B., van Birgelen A., Deslypere J.P., Penders M., van Staveren W.A. Biological markers of dietary intake, with emphasis on fatty acids. Ann Nutr Metab. 1991; 35: 249–52. doi:10.1159/000177653.; Mika A., Kobiela J., Czumaj A., Chmielewski M., Stepnowski P., Sledzinski T. Hyper-Elongation in Colorectal Cancer Tissue – Cerotic Acid is a Potential Novel Serum Metabolic Marker of Colorectal Malignancies. Cell Physiol Biochem. 2017; 41(2): 722–30. doi:10.1159/000458431.; Rifkin S.B., Shrubsole M.J., Cai Q., Smalley W.E., Ness R.M., Swift L.L., Zheng W., Murff H.J. PUFA levels in erythrocyte membrane phospholipids are differentially associated with colorectal adenoma risk. Br J Nutr. 2017; 117(11): 1615–22. doi:10.1017/S0007114517001490.; Crotti S., Agnoletto E., Cancemi G., Di Marco V., Traldi P., Pucciarelli S., Nitti D., Agostini M. Altered plasma levels of decanoic acid in colorectal cancer as a new diagnostic biomarker. Analytical and bioanalytical chemistry. 2016; 408(23): 6321–8. doi:10.1007/s00216-016-9743-1.; Kang J.X., Wang J. A simplified method for analysis of polyunsaturated fatty acids. BMC Biochem. 2005; 6: 5–13. doi:10.1186/1471-2091-6-5.; Shashkov M.V., Sidelnikov V.N. Properties of columns with several pyridinium and imidazolium ionic liquid stationary phases. J Chromatogr A. 2013; 1309: 56–63. doi:10.1016/j.chroma.2013.08.030.; Breiman L. Random Forests. Machine Learning. 2001; 45: 5–32. https://doi.org/10.1023/A:1010933404324.; Gradilla A.-C., Sanchez-Hernandez D., Brunt S., Scholpp L. From top to bottom: Cell polarity in Hedgehog and Wnt trafficking. BMC Biology. 2018; 16: 37–46. doi:10.1186/s12915-018-0511-x.; Doll S., Freitas F.P., Shah R., Aldrovandi M., da Silva M.C., Ingold I., Goya Grocin A., Xavier da Silva T.N., Panzilius E., Scheel C.H., Mourao A., Buday K., Sato M., Wanninger J., Vignane T., Mohana V., Rehberg M., Flatley A., Schepers A., Kurz A., White D., Sauer M., Sattler M., Tate E.W., Schmitz W., Schulze A., O’Donnell V., Proneth B., Popowicz G.M., Pratt D.A., Angeli J.P.F., Conrad M. FSP1 is a glutathioneindependent ferroptosis suppressor. Nature. 2019; 575(7784): 693–8. doi:10.1038/s41586-019-1707-0.; Igal R.A. Stearoyl-CoA desaturase-1: a novel key player in the mechanisms ofcell proliferation, programmed cell death and transformation to cancer. Carcinogenesis. 2010; 31: 1509–15. doi:10.1093/carcin/bgq131.; Danielsen S.A., Eide P.W., Nesbakken A., Guren T., Leithe E., Lothe R.A. Portrait of the PI3K/AKT pathway in colorectal cancer. Biochim Biophys Acta. 2015; 1855: 104–21. doi:10.1016/j.bbcan.2014.09.008.; Zhou X.P., Loukola A., Salovaara R., Nystrom-Lahti M., Peltomaki P., de laChapelle A., Aaltonen L.A., Eng C. PTEN mutational spectra, expression levels,and subcellular localization in microsatellite stable and unstable colorectalcancers. Am J Pathol. 2002; 161: 439–47. doi:10.1016/S0002-9440(10)64200-9.; Baro L., Hermoso J.C., Nunez M.C., Jimenez-Rios J.A., Gil A. Abnormalities in plasma and red blood cell fatty acid profiles of patients with colorectal cancer. Br J Cancer. 1998; 77: 1978–83. doi:10.1038/bjc.1998.328.; Veglia F., Tyurin V.A., Blasi M., De Leo A., Kossenkov A.V., Donthireddy L., To T.K.J., Schug Z., Basu S., Wang F., Ricciotti E., Di Russo C., Murphy M.E., Vonderheide R.H., Lieberman P.M., Mulligan C., Nam B., Hockstein N., Masters G., Guarino M., Lin C., Nefedova Y., Black P., Kagan V.E., Gabrilovich D.I. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. 2019; 569(7754): 73–8. doi:10.1038/s41586-019-1118-2.; Kortlever R.M., Sodir N.M., Wilson C.H., Burkhart D.L., Pellegrinet L., Swigart L.B., Littlewood T.D., Evan G.I. Myc Cooperates with Ras by Programming Inflammation and Immune Suppression. Cell. 2017; 171: 1301–15. doi:10.1016/j.cell.2017.11.013.; Singh K.B., Hahm E.R., Kim S.H., Wendell S.G., Singh S.V. A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer. Oncogene. 2021; 40(3): 592–602. doi:10.1038/s41388-020-01553-z.; Duman C., Yaqubi K., Hoffmann A., Acikgoz A.A., Korshunov A., Bendszus M., Herold-Mende C., Liu H.K., Alfonso J. Acyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation. Cell Metabolism. 2019; 30(2): 274–89. doi:10.1016/j.cmet.2019.04.004.; Aregger M., Lawson K.A., Billmann M., Costanzo M., Tong A.H.Y., Chan K., Rahman M., Brown K.R., Ross C., Usaj M., Nedyalkova L., Sizova O., Habsid A., Pawling J., Lin Z.-Y., Abdouni H., Wong C.J., Weiss A., Mero P., Dennis J.W., Gingras A.C., Myers C.L., Andrews B.J., Boone C., Moffat J. Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism. Nature Metabolism. 2020; 2: 499–513. doi:10.1038/s42255-020-0211-z.; Yessoufou A., Ple A., Moutairou K., Hichami A., Khan N.A. Docosahexaenoic acid reduces suppressive and migratory functions of CD4+CD25+ regulatory T-cells. J Lipid Res. 2009; 50: 2377–88. doi:10.1194/jlr.M900101-JLR200.; Woodworth H.L., McCaskey S.J., Duriancik D.M., Clinthorne J.F., Langohr I.M., Gardner E.M., Fenton J.I. Dietary fish oil alters T lymphocyte cell populations and exacerbates disease in a mouse model of inflammatory colitis. Cancer Res 2010; 70(20): 7960–9. doi:10.1158/0008-5472.CAN-10-1396.; Ohmori H., Fujii K., Kadochi Y., Mori S., Nishiguchi Y., Fujiwara R., Kishi S., Sasaki T., Kuniyasu H. Elaidic Acid, a Trans-Fatty Acid, Enhances the Metastasis of Colorectal Cancer Cells. Pathobiology. 2017; 84(3): 144–51. doi:10.1159/000449205.; Cockbain A.J., Toogood G.J., Hull M.A. Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer. Gut. 2012; 61: 135–49. doi:10.1136/gut.2010.233718.; https://www.siboncoj.ru/jour/article/view/2091

الاتاحة: https://www.siboncoj.ru/jour/article/view/2091
https://doi.org/10.21294/1814-4861-2022-21-2-65-80

المؤلفون: M. V. Kruchinina, Ya. I. Prudnikova, S. A. Kurilovich, A. A. Gromov, V. N. Kruchinin, V. V. Atuchin, O. V. Naumova, E. V. Spesivtsev, V. A. Volodin, S. E. Peltek, G. V. Shuvalov, V. M. Generalov, М. В. Кручинина, Я. В. Прудникова, С. А. Курилович, А. А. Громов, В. Н. Кручинин, В. В. Атучин, О. В. Наумова, Е. В. Спесивцев, В. А. Володин, С. Е. Пельтек, Г. В. Шувалов, В. М. Генералов

المصدر: Siberian journal of oncology; Том 16, № 4 (2017); 32-41 ; Сибирский онкологический журнал; Том 16, № 4 (2017); 32-41 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2017-16-4

مصطلحات موضوعية: опухолевая М2 пируваткиназа, colorectal cancer, ellipsometry, surface Plasmon resonance, fluorescence optical spectrometry, Raman spectroscopy, SOI nanowire biosensor, tumor M2 pyruvate kinase, колоректальный рак, эллипсометрия, флуоресцентная оптическая спектрометрия, поверхностный плазмонный резонанс, Raman-спектроскопия, КНИ-нанопроволочный биосенсор

وصف الملف: application/pdf

Relation: https://www.siboncoj.ru/jour/article/view/568/457; Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J Clin. 2009 Jul‑Aug; 59 (4): 225–49. doi:10.3322/caac.20006.; Cai S.R., Zhang S.Z., Zhu H.H., Huang Y.Q., Li Q.R., Ma X.Y., Yao K.Y., Zheng S. Performance of a colorectal cancer screening protocol in an economically and medically underserved population. Cancer Prev Res (Phila). 2011 Oct; 4 (10): 1572–9. doi:10.1158/1940-6207.CAPR-10-0377.; Pawlik T.M., Scoggins C.R., Zorzi D., Abdalla E.K., Andres A., Eng C., Curley S.A., Loyer E.M., Muratore A., Mentha G., Capussotti L., Vauthey J.N. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005; 241: 715–22. doi:10.1097/01.sla.0000160703.75808.7d.; Meyerhardt J.A., Mangu P.B., Flynn P.J., Corde L., Loprinzi C.L., Minsky B.D., Petrelli N.J., Ryan K., Schrag D.H., Wong S.L., Benson A.B. Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement. J Clin Oncol. 2013 Dec 10; 31 (35): 4465–70. doi:10.1200/JCO.2013.50.7442.; Bathe O.F., Ernst S., Sutherland F.R., Dixon E., Butts C., Bigam D., Holland D., Porter G.A., Koppel J., Dowden S. A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases. BMC Cancer. 2009; 9: 156–67. doi:10.1186/1471-2407-9-156.; Pawlik T.M., Schulick R.D., Choti M.A. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008; 13: 51–64. doi:10.1634/theoncologist.2007-0142.; Shah S.A., Bromberg R., Coates A., Rempel E., Simunovic M., Gallinger S. Survival after liver resection for metastatic colorectal carcinoma in a large population. J Am Coll Surg. 2007; 205: 676–83. doi:10.1016/j.jamcollsurg.2007.06.283.; Wild N., Andres H., Rollinger W., Krause F., Dilba P., Tacke M., Karl J. A combination of serum markers for the early detection of colorectal cancer. Clin Cancer Res. 2010; 16: 6111–21. doi:10.1158/1078-0432.CCR-10-0119.; Shastri Y.M., Stein J.M. Faecal tumour pyruvate kinase M2: not a good marker for the detection of colorectal adenomas. Br J Cancer. 2008 Sep 30; 99: 1366, author reply 1367. doi:10.1038/sj.bjc.6604656.; Jonkheijm P., Weinrich D., Schroder H., Niemeyer C.M., Waldmann H. Chemical Strategies for Generating Protein Biochips. Angew Chem Int Ed Engl. 2008; 47: 9618–47. doi:10.1002/anie.200801711.; Рыхлицкий С.В., Кручинин В.Н., Швец В.А., Спесивцев Е.В., Прокопьев В.Ю. Спектральный плазмон-эллипсометрический комплекс «Эллипс-СПЭК». Приборы и техника эксперимента. 2013; 1: 137–138. doi:10.7868/S0032816212060092.; Спесивцев Е.В., Рыхлицкий С.В., Назаров Н.И. Автоматический сканирующий микроэллипсометр. Автометрия. 1997; 1: 100–5.; Власов В.В., Синяков А.Н., Пышный Д.В., Рыхлицкий С.В., Кручинин В.Н., Спесивцев Е.В., Пышная И.А., Костина Е.В., Дмитриенко Е.Д., Бессмельцев В.П. Эллипсометрический мониторинг в микрочиповых label-free биотехнологиях. Автометрия. 2011; 47 (5): 67–7; Dmitrienko E., Naumova O., Fomin B., Kupryushkin M., Volkova A., Amirkhanov N., Semenov D., Pyshnaya I., Pyshnyi D. Surface modification of SOI-FET sensors for label-free and specific detection of short RNA analyte. Nanomedicine. 2016; 11 (16): 2073–2082.; Иванов Ю.Д., Плешакова Т.О., Козлов А.Ф., Мальсагова К.А., Крохин Н.В., Кайшева А.Л., Шумов И.Д., Попов В.П., Наумова О.В., Фомин Б.И., Насимов Д.А., Асеев А.Л., Арчаков А.И. КНИ-нанопроволочный транзистор для детекции молекул D-NFATc1. Автометрия. 2013; 49 (5): 119–126.; Naumova O.V., Popov V.P., Safronov L.N., Fomin B.I., Nasimov D.A., Latyshev A.V., Aseev A.L., Ivanov Yu.D., Archakov A.I. Ultra-Thin SOI Layer Nanostructuring and Nanowire Transistor Formation for Femto-Mole Electronic Biosensors. ECS Transactions. 2009; 25 (10): 83–87. doi:10.1149/1.3241580.; Demir A.S., Erdenen F., Muderrisoglu C., Toros A.B., Bektas H., Gelisgen R., Tabak O., Altunoglu E., Uzun H., Erdem Huq G., Aral H. Diagnostic and prognostic value of tumor M2-pyruvate kinase levels in patients with colorectal cancer. Turk J Gastroenterol. 2013; 24(1): 36–42. doi:10.4318/tjg.2013.0607.; Meng W., Zhu H.H., Xu Z.F., Cai S.R., Dong Q., Pan Q.R., Zheng S., Zhang S.Z. Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening. World J Gastrointest Oncol. 2012 June 15; 4 (6): 145–51. doi:10.4251/wjgo.v4.i6.145.; Tonus C., Neupert G., Sellinger M. Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK. World J. Gastroenterol. 2006; 12 (43): 7007–11. doi:10.3748/wjg.v12.i43.7007.; Kaura B., Bagga R., Patel F.D. Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma. J Obstet Gynaecol Res. 2004; 30 (3): 193–96. doi:10.1111/j.1447-0756.2004.00187.x.; Mazurek S., Boschek C.B., Hugo F., Eigenbrodt E. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol. 2005; 15: 300–8. doi:10.1016/j.semcancer.2005.04.009.; Christofk H.R., Vander Heiden M.G., Harris M.H., Ramanathan A., Gerszten R.E., Wei R., Fleming M.D., Schreiber S.L., Cantley L.C. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008; 452: 230–33. doi:10.1038/nature06734.; Walkowiak J., Banasiewicz T., Krokowicz P., Hansdorfer-Korzon R., Drews M., Herzig K.H. Fecal pyruvate kinase (M2-PK): a new predictor for inflammation and severity of pouchitis. Scand J Gastroenterol. 2005; 40 (12): 1493–4. doi:10.1080/00365520500319112.; Helm J., Choi J., Sutphen R., Barthel J.S., Albrecht T.L., Chirikos T.N. Current and evolving strategies for colorectal cancer screening. Cancer Control. 2003; 10: 193–204.; Feng S., Wang W., Tai I.T., Chen G., Chen R., Zeng H. Label-free surface-enhanced Raman spectroscopy for detection of colorectal cancer and precursor lesions using blood plasma. Biomed Optics Express. 2015; 6 (9): 3494–3502. doi:10.1364/BOE.6.003494.; Zhou Q., Peng R.Q., Wu X.J., Xia Q., Hou J.H., Ding Y., Zhou Q.M., Zhang X., Pang Z.Z., Wan D.S., Zeng Y.X., Zhang X.S. The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer. J Transl Med 2010; 8: 13 (1–9). doi:10.1186/1479-5876-8-13.; Giusca S.E., Zugun F.E., Tarcoveanu E., Carasevici E., Amalinei C., Caruntu I.D. Immunohistochemical study of colorectal cancer liver metastases: the immune/inflammatory infiltrate. Rom J Morphol Embryol. 2010; 51 (1): 73–79.; Meyerhardt J.A., Tepper J.E., Venook A. Special Series: Advances in GI Cancer. J Clin Oncol. 2015 Jun 1; 33 (16): 1717–20. doi:10.1200/JCO.2015.60.8661.; Карякин А.А., Уласова Е.А., Вагин М.Ю., Карякина Е.Е. Биосенсоры: устройство, классификация и функциональные характеристики. Сенсор. 2002; 1: 16–24.; Zhang G.J., Ning Y. Silicon nanowire biosensor and its applications in disease diagnostics: a review. Anal Chim Acta. 2012; 749: 1–15. doi:10.1016/j.aca.2012.08.035.; Yang F., Zhang G.J. Silicon nanowire-transistor biosensor for study of molecule-molecule interactions. Rev Anal Chem. 2014; 33 (2): 95–110. doi 10.1515/revac-2014-0010.; Наумова О.В., Фомин Б.И. Оптимизация отклика нанопроволочных биосенсоров. Автометрия. 2016; 52 (5): 21–25.; https://www.siboncoj.ru/jour/article/view/568

الاتاحة: https://www.siboncoj.ru/jour/article/view/568
https://doi.org/10.21294/1814-4861-2017-16-4-32-41